Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03035708 · ClinicalTrials.gov registry record · Phase 1

Human Laboratory Study of Varenicline for Alcohol Use Disorder

A Phase 1 study of Alcohol Use Disorder, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).

Completed
Registry status
Phase 1
Development phase
47
Enrollment target
2
Study locations

NCT03035708 is a Phase 1 study of Alcohol Use Disorder that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 47 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03035708, a Phase 1 study of Alcohol Use Disorder, has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).

COMPLETED
Registry status
Phase 1
Development phase
47 participants
Enrollment target
2
Study locations

Study Summary

This study is a double-blind, randomized, placebo-controlled, parallel group, two-site study designed to assess the effects of varenicline as compared with placebo on responses to in vivo alcohol cue exposure in the human laboratory setting.

Conditions Studied

Alcohol Use Disorder

Interventions

  • DRUG Varenicline
  • DRUG Placebo oral capsule

Study Locations (2)

Connecticut

  • Yale University School of Medicine - New Haven

Rhode Island

  • Brown University - Providence

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2017-05-01
Est. Completion 2018-07-07
Phase Phase 1

Sponsor

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

93 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03035708

The ClinicalTrials.gov registry entry for NCT03035708 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (86% lower). The listed sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Varenicline is the first listed.

NCT03035708 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT03035708 about?

NCT03035708 is a clinical study titled "Human Laboratory Study of Varenicline for Alcohol Use Disorder". This study is a double-blind, randomized, placebo-controlled, parallel group, two-site study designed to assess the effects of varenicline as compared with placebo on responses to in vivo alcohol cue exposure in the human laboratory setting.

What is the current status of trial NCT03035708?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 47 participants. The study started on 2017-05-01. Estimated completion is 2018-07-07.

What conditions does trial NCT03035708 study?

This clinical trial studies the following conditions: Alcohol Use Disorder.

What interventions are being tested in trial NCT03035708?

The interventions under investigation include: Varenicline (DRUG), Placebo oral capsule (DRUG).

Who is sponsoring clinical trial NCT03035708?

This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03035708 being conducted?

This trial has 2 study locations across Connecticut, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alcohol Use Disorder

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.